Purpose:
To advocate for the MedTech industry with relevant stakeholders across the key areas in healthcare policy, reimbursement, regulatory, industry development and sustainability. The Committee provides oversight of Reimbursement, Industry Policy subcommittees for coordinated and aligned strategies and communications.
Objectives:
- Develop and implement an advocacy program which includes active stakeholder engagement to promote the policy positions on strategic issues identified by its subcommittees.
- Oversee implementation and content of the Digital Advocacy Platform.
MTAA Secretary: Rachel Fry, Government Affairs & Communications Manager
Member Name | Company |
Andrew Wiltshire (Chair and Board Representative) | Medtronic Australasia Pty Ltd |
Chris Szeleczky (Board Representative) | Olympus Australia |
Michael Simmonds (Chair of Reimbursement Committee) | Boston Scientific |
Daniel Kildea (Chair of Industry Policy Committee | Johnson & Johnson Medical |
George Faithful (Chair of Regulatory Affairs Committee) | Stryker Australia |
Beth Roberts | KLS Martin Australia |
Clinton Lubcke | Baxter Healthcare Pty Ltd |
Fraser Cleave | LifeHealthcare Pty Ltd |
James Doyle | Stryker Australia Pty Ltd |
Jane McMillan | Johnson & Johnson Medical Pty Ltd |
Laurence Fong | Smith & Nephew Pty Ltd |
Michael Reynolds | Biotronik Australia Pty Ltd |
Natalie Lawandi | Medtronic Australasia Pty Ltd |
Paul Davies | Abbott Medical Australia Pty Ltd |
Polo Guilbert-Wright | Edwards Lifesciences Pty Ltd |
Robyn Chu | Alcon Laboratories (Australia) Pty Ltd |
Meeting dates for 2020:
- Wednesday 5th February
- Tuesday 24th March
- Wednesday 3rd June
- Tuesday 11th August
- Tuesday 13th October
- Tuesday 24th November
